Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production
Arthritis Research & Therapy, 11/25/09
Cutolo M et al. – Optimal concentrations of CTLA4-Ig for the CTLA4-Ig/B7.2 masking on activated macrophages were identified and were found to induce significant downregulation in the cell production of IL-6, TNFalpha, IL1-beta and TGFbeta. In conclusion, macrophages would appear to be a sensitive target for CTLA4-Ig treatment in RA.
Methods- All macrophages co-cultured for 24 hours with activated T cells, without or with CTLA4-Ig (10, 100, 500 mg/ml for 1 hour, 3 hours and overnight, respectively)
- Immunofluorescence (IF) staining for B7.2, and analysis of inflammatory cytokine expression (interleukin(IL)-6, tumor necrosis factor(TNF)alfa, IL-1beta, transforming growth factor(TGF)beta) by immunocytochemistry (ICC), western blot (WB) and reverse transcriptase-polymerase chain reaction (RT-PCR) performed
- Macrophages showed intense B7.2 expression
- CTLA4-Ig/B7.2 masking evident for all macrophages, even after only 1 hour of cell culture (range from 10 to 100 mg/ml)
- ICC of co-cultures showed dose-dependent decrease in inflammatory cytokines (P<0.001 for IL-6, TNFalpha, IL-1beta and TGFbeta)
- Data confirmed by WB and RT-PCR analysis
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
Osteoporosis International, 02/09/10
The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population
Arthritis & Rheumatism, 02/09/10
S100A8 and S100A9 in experimental osteoarthritis
Arthritis Research & Therapy, 02/09/10
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: A nationwide population-based study
Annals of Rheumatic Diseases, 02/08/10
Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
Journal of Autoimmunity , 02/08/10
The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis
Clinical Rheumatology, 02/05/10
Article Search
Sponsor
Sponsor


See Latest Articles


